Dr. Reddy's hits 52-week high on strong pipeline momentum

Dr. Reddy's shares hit a 52-week high despite USFDA observations, as investors focused on its advancing biologics pipeline and broader pharma sector rally. The stock surged 14% in recent weeks, outperforming the Nifty Pharma index. Positive sentiment stems from new product expectations and improved market outlook.

📊 STOCKS: DRREDDY | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma